Latest News and Events

GeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced toda...
Continue Reading...
GeoVax Awarded NIH Grant for HIV Vaccine Program
Supports Development of a Vaccine to Prevent Clade C HIV Prevalent in the Developing World GeoVax...
Continue Reading...
GeoVax Discusses Zika Vaccine Development at American Society for Virology’s 35th Annual Meeting
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in the development of human ...
Continue Reading...